On January 27, 2022, LBX Pharmacy Chain Joint Stock Company closed the transaction. The company issued 39,927,820 A shares at issue price of CNY 43.59 per share for gross proceeds of CNY 1,740,453,673.80 in the transaction. The company paid issuance expenses of CNY 15,179,765.29 excluding tax and received net proceeds of CNY 1,725,273,908.51.

The transaction included participation from new investor Guangdong Hengkuo Investment Management Co., Ltd. for 6,859,371 shares for CNY 298,999,982, Guotai Asset Management Co., Ltd. for 4,312,915 shares for CNY 187,999,965, China Asset Management Co., Ltd. for 2,844,689 shares for CNY 123,999,994 and others. The China Securities Regulatory Commission's reply on approval of the transaction under ( [2021] No. 2294).